Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Maravai Lifesciences Holdings Inc Cl A (NQ: MRVI )

5.075 -2.765 (-35.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Maravai Lifesciences Holdings Inc Cl A

< Previous 1 2 3 4 5 6 7 8 9 Next >
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Decoding 5 Analyst Evaluations For Maravai LifeSciences
Via Benzinga
This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Maravai LifeSciences Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Via Benzinga
Unveiling 4 Analyst Insights On Maravai LifeSciences
Via Benzinga
Where Maravai LifeSciences Stands With Analysts
Via Benzinga
Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript
MRVI earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research
From Maravai LifeSciences, Inc.
Via Business Wire
Maravai LifeSciences Reports Third Quarter 2024 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase
From TriLink BioTechnologies
Via Business Wire
Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits
From TriLink BioTechnologies
Via Business Wire
Wall Street Ticks Up As Consumer Sentiment Improves; Gold Hits Record Highs, Boosting Mining Stocks: What's Driving Markets Friday?
Wall Street edged slightly higher on Friday, with major equity indices showing modest gains at midday in New York. 
Via Benzinga
Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript
MRVI earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Maravai LifeSciences Reports Second Quarter 2024 Financial Results
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Appoints Trey Martin to Board of Directors
Maravai announces the appointment of CEO Trey Martin to its Board of Directors, highlighting his leadership, commitment to innovation, and industry experience 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
From TriLink BioTechnologies
Via Business Wire
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript
MRVI earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
MRVI Stock Earnings: Maravai LifeSciences Beats EPS, Beats Revenue for Q1 2024
MRVI stock results show that Maravai LifeSciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Maravai LifeSciences Reports First Quarter 2024 Financial Results
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
From TriLink BioTechnologies
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.